UBS - Nasdaq Dips Over 300 Points; PepsiCo Reports Weak Sales | Benzinga
U.S. stocks traded mixed midway through trading, with the Nasdaq Composite falling more than 300 points on Thursday.
The Dow traded up 0.21% to 39,803.00 while the NASDAQ fell 1.81% to 18,310.23. The S&P 500 also fell, dropping, 0.84% to 5,586.74.
Check This Out: Top 4 Real Estate Stocks That Could Lead To Your Biggest Gains In Q3
Leading and Lagging Sectors
Real estate shares jumped by 2.8% on Thursday.
In trading on Thursday, information technology shares fell by 2.7%.
Top Headline
PepsiCo Inc (NASDAQ:PEP) reported worse-than-expected second-quarter FY24 revenue.
The company reported second-quarter sales growth of 0.8% year-on-year to $22.501 billion, missing the analyst consensus estimate of $22.599 billion. Adjusted EPS of $2.28 beat the consensus estimate of $2.16.
Equities Trading UP
- Biodexa Pharmaceuticals Plc (NASDAQ:BDRX) shares shot up 50% to $1.0675 after the company reported 12-month Phase 2 trial results for eRapa in treating Familial Adenomatous Polyposis.
- Shares of Volcon, Inc. (NASDAQ:VLCN) got a boost, surging 42% to $5.20 in response to a series of buy-sell transactions by UBS Group AG (NYSE:UBS).
- Renalytix Plc (NASDAQ:RNLX) shares were ...